Embark Stock

embarkvet.comHealthcare / BioTech & PharmaFounded: 2015Funding to Date: $94.55MM

Embark is a provider of dog DNA tests and developer of a powerful platform for scientific discovery designed to accelerate advancements in personalized dog care.

Register To Buy and Sell Shares

For more details on financing and valuation for Embark, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Embark’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Embark.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Ryan Boyko
Founder & Chief Executive Officer
Isabelle Plante
Chief Marketing Officer
Adam Medros
Chief Operating Officer
Matt Barton
Chief Technology Officer
Steve Boulanger
Chief Financial Officer

Board Members

Carlos D. Bustamante
Department of Biomedical Data Science
Margret L. Casal
Diplomate of the European College of Animal Reproduction
Joe Wakshlag
University of Florida College of Veterinary Medicine
Rodney Page
Colorado State University
Updated on: Dec 3, 2023


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.